Data Year:

For its 2025 fiscal year, BAXTER INTERNATIONAL INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
José E. Almeida
Former Chair of the Board, President and CEO
Total Compensation $7,666,044 View details Pay Rank By Title In MFG Durable industry #279 View more
David Rosenbloom
Executive Vice President and General Counsel
Total Compensation $3,794,164 View details Pay Rank By Title In MFG Durable industry #84 View more
Brent Shafer
Non-Executive Chair and Former Executive Chair and Interim CEO
Total Compensation $3,809,993 View details Pay Rank By Title In MFG Durable industry #6 View more
Heather Knight
Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies
Total Compensation $6,074,548 View details Pay Rank By Title In MFG Durable industry #31 View more
Joel Grade
Former Executive Vice President and CFO
Total Compensation $8,209,568 View details Pay Rank By Title In MFG Durable industry #38 View more
Alok Sonig
Former Executive Vice President and Group President, Pharmaceuticals
Total Compensation $5,239,273 View details Pay Rank By Title In MFG Durable industry #50 View more
Andrew Hider
President and CEO
Total Compensation $29,805,182 View details Pay Rank By Title In MFG Durable industry #16 View more
Cecilia Soriano
Group President, Infusion Therapies & Technologies and Pharmaceuticals
Total Compensation $2,654,841 View details Pay Rank By Title In MFG Durable industry #74 View more
Reazur Rasul
Executive Vice President and Group President, Healthcare Systems & Technologies
Total Compensation $5,246,214 View details Pay Rank By Title In MFG Durable industry #49 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at BAXTER INTERNATIONAL INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. BAXTER INTERNATIONAL INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. BAXTER INTERNATIONAL INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
José E. Almeida
Former Chair of the Board, President and CEO
Total Cash $660,420 Equity $0 Other $7,005,624 $7,666,044
David Rosenbloom
Executive Vice President and General Counsel
Total Cash $1,108,840 Equity $2,616,381 Other $68,943 $3,794,164
Brent Shafer
Non-Executive Chair and Former Executive Chair and Interim CEO
Total Cash $1,356,483 Equity $2,400,815 Other $52,695 $3,809,993
Heather Knight
Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies
Total Cash $747,123 Equity $5,285,630 Other $41,795 $6,074,548
Joel Grade
Former Executive Vice President and CFO
Total Cash $1,286,825 Equity $6,859,043 Other $63,700 $8,209,568
Alok Sonig
Former Executive Vice President and Group President, Pharmaceuticals
Total Cash $779,747 Equity $4,439,949 Other $19,577 $5,239,273
Andrew Hider
President and CEO
Total Cash $2,319,440 Equity $26,318,571 Other $1,167,171 $29,805,182
Cecilia Soriano
Group President, Infusion Therapies & Technologies and Pharmaceuticals
Total Cash $1,034,979 Equity $1,553,619 Other $66,243 $2,654,841
Reazur Rasul
Executive Vice President and Group President, Healthcare Systems & Technologies
Total Cash $1,288,000 Equity $3,884,928 Other $73,286 $5,246,214
For its 2025 fiscal year, BAXTER INTERNATIONAL INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Andrew Hider CEO Pay $32,199,341 Median Employee Pay $72,402 CEO Pay Ratio 445:1
For its 2025 fiscal year, BAXTER INTERNATIONAL INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Amy A. Wendell Total Cash $354,987
Brent Shafer Total Cash $109,646
Cathy R. Smith Total Cash $364,987
David S. Wilkes, M.D. Total Cash $366,848
Jeffrey A. Craig Total Cash $359,987
Nancy M. Schlichting Total Cash $393,565
Patricia B. Morrison Total Cash $361,585
Stephen H. Rusckowski Total Cash $354,987
Stephen N. Oesterle, M.D. Total Cash $374,487
William A. Ampofo, II Total Cash $337,436
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.